Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.

MLA

Miyata, Koichi, et al. “Infliximab for Intensification of Primary Therapy for Patients with Kawasaki Disease and Coronary Artery Aneurysms at Diagnosis.” Archives of Disease in Childhood, vol. 108, no. 10, Oct. 2023, pp. 833–38. EBSCOhost, https://doi.org/10.1136/archdischild-2023-325639.

APA

Miyata, K., Bainto, E. V., Sun, X., Jain, S., Dummer, K. B., Burns, J. C., & Tremoulet, A. H. (2023). Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis. Archives of Disease in Childhood, 108(10), 833–838. https://doi.org/10.1136/archdischild-2023-325639

Chicago

Miyata, Koichi, Emelia V Bainto, Xiaoying Sun, Sonia Jain, Kirsten B Dummer, Jane C Burns, and Adriana H Tremoulet. 2023. “Infliximab for Intensification of Primary Therapy for Patients with Kawasaki Disease and Coronary Artery Aneurysms at Diagnosis.” Archives of Disease in Childhood 108 (10): 833–38. doi:10.1136/archdischild-2023-325639.